Catheter ablation: A new first-line treatment option for atrial fibrillation

FHS
July 21, 2023
1:58 am

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.

Scientists investigate a bat virus with pandemic potential

The devastating COVID-19 pandemic occurred when the SARS-CoV-2 virus, native to a species of bats, mutated to infect humans.

July 10, 2023

BGI Genomics enhances NIFTY prenatal testing kit with DNBSEQ-G99 platform for faster and accurate results

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an

February 22, 2024

Actimed plans trials to treat muscle wasting syndrome in cancer patients

Actimed plans to start two Phase IIb/III trials of its lead candidate in H1 2024. Credit: Shutterstock / Casa nayafana. UK-based Actimed Therapeutics is planning

July 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.